A
Anna Krasnodembskaya
Researcher at Queen's University Belfast
Publications - 57
Citations - 4626
Anna Krasnodembskaya is an academic researcher from Queen's University Belfast. The author has contributed to research in topics: Mesenchymal stem cell & ARDS. The author has an hindex of 16, co-authored 49 publications receiving 2919 citations. Previous affiliations of Anna Krasnodembskaya include University of California & University of California, San Francisco.
Papers
More filters
Journal ArticleDOI
Healthy versus inflamed lung environments differentially effect MSCs
Sara Rolandsson Enes,Sara Rolandsson Enes,Thomas H. Hampton,Jayita Barua,David H. McKenna,Claudia C. dos Santos,Eyal Amiel,Alix Ashare,Alix Ashare,Kathleen D. Liu,Anna Krasnodembskaya,Karen English,Bruce A. Stanton,Patricia R. M. Rocco,Patricia R. M. Rocco,Michael A. Matthay,Daniel J. Weiss +16 more
TL;DR: In this article, mesenchymal stromal cells (MSC) were exposed to bronchoalveolar lavage fluid (BALF) samples obtained from ARDS patients or from healthy volunteers.
Journal ArticleDOI
Therapeutic targeting of metabolic alterations in acute respiratory distress syndrome.
TL;DR: Metabolomic analysis has made initial steps in characterising the underlying metabolic derangements of ARDS as an indicator of phenotypical class and mitochondrial dysfunction as a potential therapeutic target.
Journal ArticleDOI
Repair of acute respiratory distress syndrome by stromal cell administration (REALIST) trial: A phase 1 trial.
Ellen Gorman,Manu Shankar-Hari,Manu Shankar-Hari,Phil Hopkins,William Tunnicliffe,Gavin D. Perkins,Jonathan A Silversides,Jonathan A Silversides,Peter McGuigan,Anna Krasnodembskaya,Colette Jackson,Roisin Boyle,Jamie McFerran,Cliona McDowell,Christina Campbell,Margaret McFarland,Jon Smythe,Jacqui Thompson,Barry Williams,Gerard F. Curley,John G. Laffey,Mike Clarke,Daniel F. McAuley,Cecilia O'Kane +23 more
TL;DR: The REALIST phase 1 trial as mentioned in this paper investigated the safety and feasibility of ORBCEL-C in patients with moderate to severe acute respiratory distress syndrome (ARDS) due to immunomodulatory, reparative, and antimicrobial actions.
Journal ArticleDOI
[Interaction of Arenicin-1 with C1q Protein].
M. N. Berlov,Ekaterina S. Umnyakova,T. S. Leonova,B. L. Milman,Anna Krasnodembskaya,Tatiana V. Ovchinnikova,V. N. Kokryakov +6 more
TL;DR: The interaction of arenicin-1, an antimicrobial peptide from the lugworm Arenicola marina with the protein C1q of the human complement system has been analyzed using enzyme-linked receptor sorbent assay and ELISA.
Journal ArticleDOI
Research Progress on Strategies that can Enhance the Therapeutic Benefits of Mesenchymal Stromal Cells in Respiratory Diseases With a Specific Focus on Acute Respiratory Distress Syndrome and Other Inflammatory Lung Diseases
Sara Rolandsson Enes,Anna Krasnodembskaya,Karen English,Claudia C. dos Santos,Daniel J. Weiss +4 more
TL;DR: The authors provided an overview on advances and current issues with a focus on mesenchymal stromal cells (MSCs) based cell therapies for inflammatory acute respiratory distress syndrome varieties and other inflammatory lung diseases.